Caxton Associates (UK)’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$940K Buy
5,238
+1,867
+55% +$319K 0.02% 390
2025
Q4
$477K Buy
+3,371
New +$383K 0.01% 513

Other funds holding ALB

Caxton Associates (UK)'s ALB Position: Q1 2026 in Review

Caxton Associates (UK) increased its Albemarle (ALB) stake by 55% in Q1 2026, buying an estimated $319K and bringing the position to 5,238 shares worth $940K. The position accounts for 0.02% of the portfolio, ranked #390.

Caxton Associates (UK) first reported a position in ALB in Q4 2025 and has held it in 2 quarters since. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Caxton Associates (UK) held 5,238 shares of Albemarle worth $940K as of Q1 2026.
  • Caxton Associates (UK) bought 1,867 Albemarle shares in Q1 2026, an estimated $319K.
  • Albemarle made up 0.02% of Caxton Associates (UK)'s portfolio in Q1 2026, its #390 holding.
  • Caxton Associates (UK) first reported a position in Albemarle in Q4 2025 and has held it in 2 quarters since.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.